Please assess the completion status of the following clinical trial:

Trial Title: Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Reduced tear film break up time (TBUT), a sign of dry eye disease and contact lens discomfort~* Scleral lens wearer (at least 8 hours per day for at least 5 days per week and have had their habitual lenses no longer than 1 year). Scleral lenses wear will be defined as 15.00 mm to 19.00 mm inclusive.~Exclusion Criteria:~* Disorders that affect sensitivity (herpetic disease, severe diabetes mellitus)~* Anatomic variations of the conjunctiva that can impair proper scleral lens fitting~* Pregnancy~* Best corrected Snellen visual acuity worse than 20/30 in either eye~* Ocular pathology other than dry eye (e.g. glaucoma, macular degeneration, keratoconus) which may significantly impact visual function.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Treated followed by untreated (Type: EXPERIMENTAL): Patients wear the Hydra-PEG treated scleral lenses for 30 days. After testing and a post contact lens wear washout period, these patients will then wear the untreated lenses for 30 days. In this arm, the intervention (scleral lenses treated with Tangible Hydra-PEG) is administered prior to the control treatment (untreated scleral lenses).
- Untreated followed by treated (Type: EXPERIMENTAL): Patients wear the untreated scleral lenses for 30 days. After testing and a post contact lens wear washout period, these patients will then wear the Hydra-PEG treated lenses for 30 days. In this arm, the intervention (scleral lenses treated with Tangible Hydra-PEG) is administered after the control treatment (untreated scleral lenses).

Based on this trial design, predict the completion outcome and termination type (if applicable).